The incidence of major vascular injury in gynecologic laparoscopy for benign indication remains very low at 0.082%. The majority of reported MVIs were lacerations of the epigastric vessels during trocar placement. The risk of mortality from a MVI during laparoscopic surgery was extremely low at 0.001%. Laparoscopy remains a low risk procedure in relation to vascular injuries when performed for benign gynecologic diseases.
103 Impact of obesity on cost of hysterectomy performed by fellowship trained minimally invasive gynecologic surgeons 
MATERIALS AND METHODS:
We performed a retrospective cohort study at a single academic center. Patients included all women undergoing either a traditional laparoscopic hysterectomy or roboticassisted laparoscopic hysterectomy between 2012 and 2017. Patients were excluded if their surgery was performed by anyone other than those surgeons with subspecialty training in minimally invasive gynecologic surgery. BMI was stratified as follows: underweight/ normal (<18.5 e 24.9), overweight (25 e 29.9), obese (30 e 34.9), and extreme obesity (> 35). Univariate analysis was performed to determine distributions of continuous and categorical variables.
Bivariate analysis, propensity scoring, and regression analysis were used where appropriate. RESULTS: We identified 609 patients that underwent hysterectomy during the study period. Three hundred and fifty-one women (57.6%) underwent robotic hysterectomy and 258 women (42.4%) underwent traditional laparoscopic hysterectomy. Demographic data were similar between these two groups. BMI was not significantly different across the two groups (p¼.10). There was no statistically significant difference in complication rate between the two groups (p¼.76). Total operative time, complication rate, and length of hospital stay were not significantly different between obese and nonobese patients (p¼.47, p¼.76, p¼.78, respectively). With regard to cost BMI did not have any statistically significant impact across surgery groups (p¼.81). When stratified by obese versus non-obese cost remained unaffected ($6175.23 vs. $6200.25; p¼.40, respectively) . Mean cost was highest in the overweight group ($6262.43) and lowest in the underweight/normal group ($6126.96), though this did not reach statistical significance (p¼.55). Scatterplots to assess relationships did find that cost does increase slightly as BMI increases until between a BMI of 30-35. Conversion to laparotomy was not impacted by BMI with an overall incidence of 0.16%. CONCLUSION: In this study, obesity did not impact cost of minimally invasive hysterectomy. There was a trend towards increased cost as BMI increased which plateaus between a BMI of 30 and 35. Certain factors are known to increase the cost of hysterectomy including intraoperative and postoperative complications, conversion to laparotomy, prolonged operative time, and increased length of hospital stay. Our findings show that these factors, known to increase the cost of healthcare, are mitigated when patients are under the care of highvolume fellowship trained gynecologic surgeons.
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